Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: Progress-Werk Oberkirch AG: PWO wins another major order and raises annual forecast for new business
DGAP-News: Progress-Werk Oberkirch AG: PWO wins another major order and raises annual forecast for new business
DGAP-News: Progress-Werk Oberkirch AG: PWO wins another major order and raises annual forecast for new business
DGAP-News: Progress-Werk Oberkirch AG: PWO gewinnt einen weiteren Großauftrag und hebt Jahresprognose für das Neugeschäft an
DGAP-News: Progress-Werk Oberkirch AG: PWO gewinnt einen weiteren Großauftrag und hebt Jahresprognose für das Neugeschäft an
DGAP-News: Progress-Werk Oberkirch AG: PWO gewinnt einen weiteren Großauftrag und hebt Jahresprognose für das Neugeschäft an
DGAP-News: HanseYachts Aktiengesellschaft: Interim Report of the management on the first quarter of 2021 / 2022
DGAP-News: HanseYachts Aktiengesellschaft: Interim Report of the management on the first quarter of 2021 / 2022
DGAP-News: HanseYachts Aktiengesellschaft: Interim Report of the management on the first quarter of 2021 / 2022
DGAP-News: HanseYachts Aktiengesellschaft: Zwischenmitteilung der Geschäftsführung über 1. Quartal 2021/2022
DGAP-News: HanseYachts Aktiengesellschaft: Zwischenmitteilung der Geschäftsführung über 1. Quartal 2021/2022
DGAP-News: HanseYachts Aktiengesellschaft: Zwischenmitteilung der Geschäftsführung über 1. Quartal 2021/2022
Unlocking Growth: Why Arcos Dorados Belongs in Your Portfolio: https://www.marketbeat.com/logos/articles/med_20240814133928_chart-arco-8142024.png
Unlocking Growth: Why Arcos Dorados Belongs in Your Portfolio

There are many reasons to buy Arcos Dorados (NYSE: ARCO), but they center on the company’s leadership in the Latin American QSR industry and its growing moat. Arcos Dorados is the largest

Crocs Stock Slips After Earnings Beat: Will It Bounce Back?: https://www.marketbeat.com/logos/articles/med_20240812160720_crocs-stock-slips-after-earnings-beat-will-it-boun.jpg
Crocs Stock Slips After Earnings Beat: Will It Bounce Back?

Casual footwear maker Crocs Inc. (NASDAQ: CROX) reported solid Q2 2024 results, but shares initially sold off. The maker of iconic clog-style shoes made from its proprietary Croslite foam

Brinker International’s Price Dip is an Appetizing Entry Point: https://www.marketbeat.com/logos/articles/med_20240814111521_brinker-internationals-price-dip-is-an-appetizing.png
Brinker International’s Price Dip is an Appetizing Entry Point

Brinker International’s (NYSE: EAT) stock price fell 15% following its Q4 release, which presented an appetizing dip for investors to snack on. Weaker-than-expected earnings and

Which Pet Stock Should Get Your Tail Wagging in 2024?: https://www.marketbeat.com/logos/articles/med_20240812152746_which-pet-stock-should-get-your-tail-wagging-in-20.jpg
Which Pet Stock Should Get Your Tail Wagging in 2024?

It’s not a sector as red-hot as artificial intelligence, but pet stocks warrant investor attention in 2024. According to PetExec, U.S. households spend over $136 billion per year on their pets

Loar Holdings Inc. Reports Q2 2024 Results and Upward Revision to Guidance: https://www.irw-press.at/prcom/images/messages/2024/76528/LoarHoldingsNR08132024_PRcom.004.png
Loar Holdings Inc. Reports Q2 2024 Results and Upward Revision to Guidance

WHITE PLAINS, NY / ACCESSWIRE / August 13, 2024 / Loar Holdings Inc. (NYSE:LOAR) (the "Company," "Loar," "we," "us" and "our"), reported record results for the second quarter of 2024.

 

EMX Executes Agreement to Sell Its Sulitjelma Project to Alpha Future Funds: https://www.irw-press.at/prcom/images/messages/2024/76478/EMX-060824_ENPRcom.002.png
EMX Executes Agreement to Sell Its Sulitjelma Project to Alpha Future Funds

Vancouver, British Columbia, August 8, 2024 (NYSE American: EMX; TSX Venture: EMX; Frankfurt: 6E9) — EMX Royalty Corporation (the “Company” or “EMX”) is pleased to announce the execution of

Big Screen Stock Soars on Blockbuster Q2 Earnings: https://www.marketbeat.com/logos/articles/med_20240728180207_chartx-imax.jpg
Big Screen Stock Soars on Blockbuster Q2 Earnings

Entertainment technology platform operator IMAX Co. (NYSE: IMAX) stock hit 52-week highs following its robust Q2 2024 earnings release. The company has been able to survive and thrive in the

Survey: Top 175 Fittest Retirement Locations in America: https://www.marketbeat.com/logos/articles/med_20240729111005_survey-top-175-fittest-retirement-locations-in-ame.jpg
Survey: Top 175 Fittest Retirement Locations in America

We recently ran a survey of 3,000 respondents to identify where in America the most active retirees reside. The findings are outlined below:

Key Insights

Geographical Diversity

  • Coastal
Time to Take a Bite of This Stock's Enticing Value: https://www.marketbeat.com/logos/articles/med_20240729075303_chart-mcd-7292024.png
Time to Take a Bite of This Stock's Enticing Value

McDonald’s (NYSE: MCD) Q2 results weren’t awesome, but the miss was slim compared to the consensus estimates, and revision trends suggest the market was secretly expecting worse. All but one

Why Bank of America Just Approved a Huge Stock Buyback Program: https://www.marketbeat.com/logos/articles/med_20240728195050_why-bank-of-america-just-approved-a-huge-stock-buy.jpg
Why Bank of America Just Approved a Huge Stock Buyback Program

As the market rotation gets underway, with traders and investors showing growth in preferences for small-cap stocks and bonds, a few other cogs in the machine need to be in place first

Top 3 Small Cap Stocks Emerging as Rotation Winners: https://www.marketbeat.com/logos/articles/med_20240725103117_top-3-small-cap-stocks-emerging-as-rotation-winner.jpg
Top 3 Small Cap Stocks Emerging as Rotation Winners

Investors who remained heavily invested in the technology sector should start watching the broader market’s behavior today, as names in artificial intelligence like NVIDIA Co. (NASDAQ: NVDA) are

Will This Pet Retailer's Stock Break Out of the Doghouse?: https://www.marketbeat.com/logos/articles/med_20240721161106_chartm-chwy.jpg
Will This Pet Retailer's Stock Break Out of the Doghouse?

Online pet supplies retailer Chewy Inc. (NYSE: CHWY) shares are up nearly 8% year-to-date (YTD). The stock made headlines as the latest meme stock position taken by infamous investor Keith Gill

Why This Retail Stock Is on Track to Hit a Multiyear High: https://www.marketbeat.com/logos/articles/med_20240715135207_chart-psmt-7152024ver001.png
Why This Retail Stock Is on Track to Hit a Multiyear High

PriceSmart (NASDAQ: PSMT) has been biding its time for the last few years, growing its network and building leverage for investors. The company is well-positioned within the retail market

Top 3 Retail Stocks Defying the Earnings Trend: AEO, PLAY, ROST: https://www.marketbeat.com/logos/articles/med_20240705073645_top-3-retail-stocks-defying-the-earnings-trend-aeo.jpg
Top 3 Retail Stocks Defying the Earnings Trend: AEO, PLAY, ROST

One of the most closely watched economic indicators is the monthly report on retail sales. In June 2024, the May numbers were reported. After being negative in April, retail sales were up 1.2%

Clarivate: The Cheapest AI Stock Worth Buying?: https://www.marketbeat.com/logos/articles/med_20240703082642_chart-clvt-732024ver001.png
Clarivate: The Cheapest AI Stock Worth Buying?

Clarivate (NYSE: CLVT) may not be the cheapest AI stock worth buying, but it is inexpensive and set up to rebound strongly over the next few quarters. Trading at a mere 7.5x its earnings outlook

Vista Outdoor Eyes Takeover Offers: Time to Buy VSTO Stock?: https://www.marketbeat.com/logos/articles/med_20240701180030_vista-outdoor-eyes-takeover-offers-time-to-buy-vst.jpg
Vista Outdoor Eyes Takeover Offers: Time to Buy VSTO Stock?

Vista Outdoor Inc. (NYSE: VSTO) is an outdoor products company comprised of many brands in the sporting and outdoor categories. While other outdoor stocks are selling off, Vista stock trades

Applied Digital Boosts Stock with Cutting-Edge AI Data Centers: https://www.marketbeat.com/logos/articles/med_20240630174858_charty-apld.jpg
Applied Digital Boosts Stock with Cutting-Edge AI Data Centers

Applied Digital Co. (NASDAQ: APLD) designs, develops and operates next-generation data centers accommodating artificial intelligence (AI) service providers in the high-performance computing

Chewy Stock Surges on Roaring Kitty's Disclosure of Major Stake: https://www.marketbeat.com/logos/articles/med_20240701080245_chewy-stock-surges-on-roaring-kittys-disclosure-of.jpg
Chewy Stock Surges on Roaring Kitty's Disclosure of Major Stake

Chewy Inc. (NYSE: CHWY) shares spiked as much as 29% in premarket trading Monday after Keith Gill—known online as "Roaring Kitty"—disclosed a 6.6% passive stake in the online pet food and product

7 Short Squeeze Stocks to Look Into for Your Portfolio: https://www.marketbeat.com/logos/articles/med_20240626140942_7-short-squeeze-stocks-to-look-into-for-your-portf.jpg
7 Short Squeeze Stocks to Look Into for Your Portfolio

In 2021, a trader with a large Reddit following induced a massive rally in shares of GameStop Corp. (NYSE: GME). The downtrodden gaming retailer was the most shorted stock in the entire market in

Call Option Interest Soars in These 3 Stocks: https://www.marketbeat.com/logos/articles/med_20240624145754_call-option-interest-soars-in-these-3-stocks.jpg
Call Option Interest Soars in These 3 Stocks

Buying a stock is one way to expose capital to a potential upside in a company’s trajectory. Owning a stock opens the way for a one-for-one plan, as the investment will only move up or down in

Gilead Sciences Stock Surges on HIV Treatment Trial Success: https://www.marketbeat.com/logos/articles/med_20240621074929_gilead-sciences-stock-surges-on-hiv-treatment-tria.jpg
Gilead Sciences Stock Surges on HIV Treatment Trial Success

Gilead Sciences (NASDAQ: GILD) saw its stock jump nearly 10% yesterday after announcing groundbreaking results from its HIV treatment trial. The biopharmaceutical company revealed 100% efficacy in